Domínguez-Gil A - Search Results

1

Plasma protein binding kinetics of valproic acid over a broad dosage range: therapeutic implications.

Gómez Bellver MJ, García Sánchez MJ, Alonso González AC, Santos Buelga D, Domínguez-Gil A. Gómez Bellver MJ, et al. J Clin Pharm Ther. 1993 Jun;18(3):191-7. doi: 10.1111/j.1365-2710.1993.tb00612.x. J Clin Pharm Ther. 1993. PMID: 8345004 Clinical Trial.

2

Effect of dose on the kinetic behaviour of valproic acid: modifications in plasma protein binding.

Gomez MJ, Santos Buelga D, Alonso AC, Garcia MJ, Dominguez-Gil A. Gomez MJ, et al. Eur J Drug Metab Pharmacokinet. 1991;Spec No 3:239-42. Eur J Drug Metab Pharmacokinet. 1991. PMID: 1820886

3

Comparison of two methods in the estimation of the pharmacokinetic parameters of phenytoin.

Santos Buelga D, Vazquez A, Alonso AC, Garcia MJ, Dominguez-Gil A. Santos Buelga D, et al. J Clin Pharm Ther. 1990 Jun;15(3):225-31. doi: 10.1111/j.1365-2710.1990.tb00379.x. J Clin Pharm Ther. 1990. PMID: 2365758

4

Valproate population pharmacokinetics in children.

Serrano BB, García Sánchez MJ, Otero MJ, Buelga DS, Serrano J, Domínguez-Gil A. Serrano BB, et al. J Clin Pharm Ther. 1999 Feb;24(1):73-80. doi: 10.1046/j.1365-2710.1999.00202.x. J Clin Pharm Ther. 1999. PMID: 10319910

5

Population estimation of valproic acid clearance in adult patients using routine clinical pharmacokinetic data.

Blanco-Serrano B, Otero MJ, Santos-Buelga D, García-Sánchez MJ, Serrano J, Domínguez-Gil A. Blanco-Serrano B, et al. Biopharm Drug Dispos. 1999 Jul;20(5):233-40. doi: 10.1002/(sici)1099-081x(199907)20:5<233::aid-bdd179>3.0.co;2-5. Biopharm Drug Dispos. 1999. PMID: 10594867

6

Study of the disposition kinetics of the N-oxide-derivative: a metabolite of picobenzide.

Santos Buelga D, Mariño EL, Domínguez-Gil A. Santos Buelga D, et al. Eur J Drug Metab Pharmacokinet. 1989 Jan-Mar;14(1):19-22. doi: 10.1007/BF03190837. Eur J Drug Metab Pharmacokinet. 1989. PMID: 2759130

7

Predictive performance of two phenytoin pharmacokinetic dosing programs from nonsteady state data.

García MJ, Gavira R, Santos Buelga D, Dominguez-Gil A. García MJ, et al. Ther Drug Monit. 1994 Aug;16(4):380-7. doi: 10.1097/00007691-199408000-00008. Ther Drug Monit. 1994. PMID: 7974628

8

Carbamazepine population pharmacokinetics in children: mixed-effect models.

Delgado Iribarnegaray MF, Santo Bueldga D, García Sánchez MJ, Otero MJ, Falcão AC, Domínguez-Gil A. Delgado Iribarnegaray MF, et al. Ther Drug Monit. 1997 Apr;19(2):132-9. doi: 10.1097/00007691-199704000-00003. Ther Drug Monit. 1997. PMID: 9108639 Clinical Trial.

9

Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations.

del Mar Fernández De Gatta M, Santos-Buelga D, Domínguez-Gil A, García MJ. del Mar Fernández De Gatta M, et al. Clin Pharmacokinet. 2002;41(2):115-35. doi: 10.2165/00003088-200241020-00004. Clin Pharmacokinet. 2002. PMID: 11888332 Review.

10

Vancomycin dosage optimization in patients with malignant haematological disease by pharmacokinetic/pharmacodynamic analysis.

Fernández de Gatta Mdel M, Santos Buelga D, Sánchez Navarro A, Dominguez-Gil A, García MJ. Fernández de Gatta Mdel M, et al. Among authors: dominguez gil a. Clin Pharmacokinet. 2009;48(4):273-80. doi: 10.2165/00003088-200948040-00005. Clin Pharmacokinet. 2009. PMID: 19492872

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters